- Home
- GNS vs ENZ Comparison
GNS vs ENZ Comparison
Compare GNS & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- ENZ
- Stock Information
- Founded
- GNS 2002
- ENZ 1976
- Country
- GNS Singapore
- ENZ United States
- Employees
- GNS N/A
- ENZ N/A
- Industry
- GNS Other Consumer Services
- ENZ Medical Specialities
- Sector
- GNS Real Estate
- ENZ Health Care
- Exchange
- GNS Nasdaq
- ENZ Nasdaq
- Market Cap
- GNS 36.1M
- ENZ 34.2M
- IPO Year
- GNS 2022
- ENZ N/A
- Fundamental
- Price
- GNS $0.42
- ENZ $0.52
- Analyst Decision
- GNS
- ENZ
- Analyst Count
- GNS 0
- ENZ 0
- Target Price
- GNS N/A
- ENZ N/A
- AVG Volume (30 Days)
- GNS 5.7M
- ENZ 180.9K
- Earning Date
- GNS 12-27-2024
- ENZ 03-12-2025
- Dividend Yield
- GNS N/A
- ENZ N/A
- EPS Growth
- GNS N/A
- ENZ N/A
- EPS
- GNS N/A
- ENZ N/A
- Revenue
- GNS $16,147,348.00
- ENZ $30,314,000.00
- Revenue This Year
- GNS $39.87
- ENZ N/A
- Revenue Next Year
- GNS $32.96
- ENZ N/A
- P/E Ratio
- GNS N/A
- ENZ N/A
- Revenue Growth
- GNS N/A
- ENZ N/A
- 52 Week Low
- GNS $0.32
- ENZ $0.41
- 52 Week High
- GNS $6.97
- ENZ $1.40
- Technical
- Relative Strength Index (RSI)
- GNS 40.37
- ENZ 36.14
- Support Level
- GNS $0.42
- ENZ $0.46
- Resistance Level
- GNS $0.54
- ENZ $0.57
- Average True Range (ATR)
- GNS 0.06
- ENZ 0.05
- MACD
- GNS 0.01
- ENZ 0.00
- Stochastic Oscillator
- GNS 44.44
- ENZ 53.20
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.